Category: Disease States

Disease States

Researchers have developed an LIMA1-alpha assay that can identify head and neck cancer patients who can be cured with surgery alone.

Blood-based biomarker tests are revolutionizing Alzheimer's diagnostic testing and management of Alzheimer’s disease.

Diagnosing lupus remains a major challenge, but emerging biomarkers offer significant promise in improving early and accurate detection.

VieCure has partnered with Guardant Health to integrate Guardant’s precision oncology tests into the AI-powered Halo Intelligence platform.

Researchers have developed a handheld TB test that accurately detects tuberculosis in HIV-positive individuals using a single drop of blood.

Juniper Genomics has launched publicly to offer a next-generation embryo screening platform that aims to improve IVF outcomes.

rex Laboratories has launched BiomeBurden, a comprehensive test that evaluates immune responses to microbial, yeast, and mold triggers.

University of Tokyo researchers have developed a non-invasive, AI-powered imaging system that tracks platelet activity in real time.

Quest Diagnostics will offer a Fujirebio blood test this summer to enhance early detection of Alzheimer's disease.

Two studies demonstrate how AI models can significantly improve early detection of type 1 diabetes, enabling earlier intervention.

A pilot program using Healthy.io’s FDA-cleared smartphone-powered Minuteful Kidney test significantly improved CKD screening and diagnosis.

The Cystic Fibrosis Base assay has received IVDR accreditation, ensuring high standards for detecting cystic fibrosis mutations.

Researchers propose developing tiny chemical sensors that detect VOCs in bodily fluids to rapidly diagnose bacterial infections.